Podcasting is better with collaborators.

Get weekly tips, hidden gems, and real connections.
Click here to get the inside scoop—delivered weekly.

Pathocast in Review

Pathocast in Review

Pathocast in Review

We estimate there's a 100% chance this podcast is looking for guests- reach out and make your move!

Topic Category:

Science

Topic Sub-Category:

Life Sciences

Language:

English

Podcast Stats:

Number of Episodes: 1
Series Type: episodic
Content Type: AUDIO

Podcast Description

The Pathocast in Review adopts a journal club format to critically dissect the latest research in immunology, virology, and infectious disease. Join our panellist as they deep-dive into recently published studies in a roundtable discussion. Leaving no stone unturned—we cover groundbreaking work across basic science, translational research, and clinical studies that are pushing the boundaries of the field.
follow us on:
Instagram - instagram.com/pathocast_review
Tiktok - www.tiktok.com/@pathocast_rev

Podcast Insights

Content Themes

The podcast primarily focuses on the latest discoveries in immunology, with episodes covering topics such as targeting precursor B cells for broadly neutralizing antibodies and the unexpected role of antibiotics in HIV prevention for uncircumcised men. Specific discussions highlight groundbreaking research from both basic science and clinical studies that impact global health strategies.

Further Podcast insights, such as show format, guest types, ideal guests, and target audience are available to Podcast Collab Club Members!

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.

 

For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.